Insulin signal sequence

Insulin was first identified as an anti-diabetic factor in 1921, and was introduced clinically the following year. Its complete amino acid sequence was determined in 1951. Although mature insulin is a dimeric structure, it is synthesized as a single polypeptide precursor, i.e. preproinsulin. This 108 amino acid polypeptide contains a 23 amino acid signal sequence at its amino terminal end. This guides it through the endoplasmic reticulum membrane, where the signal sequence is removed by a specific peptidase. 

PTB domains (phosphotyrosine-binding domains) also bind (P)-Tyr in partner proteins, but their critical sequences and three-dimensional structures distinguish them from SH2 domains. The human genome encodes 24 proteins that contain PTB domains, including IRS-1, which we have already met in its role as a scaffold protein in insulin-signal transduction (Fig. 12-6). 

FIGURE 23-5 Insulin. Mature insulin is formed from its larger precursor preproinsulin by proteolytic processing. Removal of a 23 amino acid segment (the signal sequence) at the amino terminus of preproinsulin and formation of three disulfide bonds produces proinsulin. Further proteolytic cuts remove the C peptide from proinsulin to produce mature insulin, composed of A and B chains. The amino acid sequence of bovine insulin is shown in Figure 3-24. 

Figure 7 Maturation of insulin. Insulin is synthesized as preproinsulin that contains an N-terminal signal sequence. After translocating into the ER, the signal sequence is cleaved off by the signal peptidase and the resulting proinsulin folds into a stable conformation. Three disulfide bonds are formed between cysteine side chains. The connecting sequence (Chain C) is cleaved off in the Golgi by proprotein convertases to form the mature and active insulin molecule, which is then secreted.

No Cr-dependent enzymes or Cr-binding proteins have been identified to date. However, one chromiumbinding peptide, chromodulin, with the putative sequence pEEEEGDD (where pE is pyroglutamate) has been characterised (Chen, Watson, Gao, Sinha, Cassady, Vincent, 2011), and found to bind 4 chromic ions per peptide. It is proposed that the chromium-loaded chromodulin may function in the amplification system for insulin signalling (Vincent, 2000b) for transporting Cr " " to tissues in an insulin-responsive manner. 

---